The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global airway management devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Airway management devices are utilized for maintaining or restoring ventilation in a patient. It also involves evaluating, planning, and using different medical procedures to treat patients with respiratory failures or acute obstruction. Besides this, it protects the lungs from injury and provides gas exchange facilities to the patients. Some of the commonly used airway management devices to keep the upper airway open for offering unobstructed ventilation are supraglottic airway devices (SADs), tracheal intubation, transtracheal access, airway clearance.
The increasing prevalence of respiratory diseases represents one of the key factors driving the market. Additionally, on account of the growing number of surgeries, there is a rise in the utilization of anesthesia. This, in confluence with numerous benefits of airway management devices, such as the high efficiency in airway clearance and maintenance of proper ventilation and patient safety during operative procedures, is also contributing to the market growth. Besides this, an increase in the emergency treatment of prolonged illness and protracted treatment associated with lung diseases in children and adults is catalyzing the demand for airway management devices. Furthermore, the advent of advanced techniques for preoperative airway evaluation is also strengthening the market growth. For instance, Preoperative Endoscopic Airway Evaluation (PEAE) is a technique that identifies, predicts the blocked ventilation, and facilitates a plan for efficient management, which particularly involves the usage of advanced devices, such as supraglottic airway. These airway devices provide easy tracheal placement resulting in improved patient safety, and are subsequently utilized in a range of clinical applications.
IMARC Group provides an analysis of the key trends in each sub-segment of the global airway management devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, patient type, application and end use.
Breakup by Product:
Breakup by Patient Type:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ambu A/S, Armstrong Medical Ltd, Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd, Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH and Verathon Inc. (Roper Technologies Inc.).
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Patient Type, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Ambu A/S, Armstrong Medical Ltd, Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd, Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH and Verathon Inc. (Roper Technologies Inc.).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
We expect the global airway management devices market to exhibit a CAGR of around 6% during 2021-2026.
The rising consumer awareness towards numerous product benefits, including high efficiency in airway clearance and maintenance of proper ventilation and patient safety during operative procedures, is primarily driving the global airway management devices market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for airway management devices in maintaining or restoring ventilation in patients severely infected from the coronavirus, thereby catalyzing the overall market growth.
Based on the product, the global airway management devices market has been segmented into supraglottic devices, infraglottic devices, resuscitators, laryngoscopes, and others. Currently, infraglottic devices hold the majority of the total market share.
Based on the patient type, the global airway management devices market can be divided into adult and pediatric patient/neonates, where adult currently exhibits a clear dominance in the market.
Based on the application, the global airway management devices market has been categorized into anesthesia, emergency medicine, and others. Among these, anesthesia currently accounts for the majority of the global market share.
Based on the end use, the global airway management devices market can be segmented into hospitals, homecare, and others. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global airway management devices market include Ambu A/S, Armstrong Medical Ltd, Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd, Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH, and Verathon Inc. (Roper Technologies Inc.).
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at